LOS ANGELES, Calif., May 18, 2010 – Emmaus Medical, Inc., the privately‐held pharmaceutical company
developing and bringing to market a promising new treatment for sickle‐cell disease, announced today
that Henry (Hank) McKinnell, Jr., PhD, has joined the board of directors.
|
|
|
Home I Coporate Overview I Science and Technology I News I Contact Us I Careers
Privacy I Terms of Use I Sitemap
Emmaus Medical, Inc. Trademark Emmaus Medical, Inc, Torrance, CA. All rights reserved.
All materials (text, images, illustrations) contained on this site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of Emmaus Medical, Inc.
Web Development By:: Axiom Graphic Design Studios- www.graphicsbyaxiom.com |